Lupin LimitedNSE: LUPIN

Press Release Dec 27 2023

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-27-2023-5

Lupin Limited has informed the Exchange regarding a press release dated December 27, 2023, titled "Lupin Receives Approval from U.S. FDA for Loteprednol EtabonateOphthalmic Suspension, 0.2%.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases